v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net (loss) income $ (5,287) $ 465
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:    
Amortization of patent formulations 2,416 2,392
Amortization of other intangibles 10,820 10,893
Inventory write-off and disposal 203 1,064
Depreciation of fixed assets 82 87
Amortization of debt issuance costs 287 453
Deferred taxes (4,360) (95)
Share-based compensation expense 3,517 2,918
Other 606 309
Changes in operating assets and liabilities:    
Accounts receivable, net (8,757) (8,882)
Inventory (6,493) (5,197)
Prepaid expenses and other current assets 46,160 (6,350)
Accounts payable 21,041 13,836
Accrued expenses and other current liabilities (52,476) (12,474)
Other assets and liabilities (260) (2,336)
Net cash provided by (used in) operating activities 7,499 (2,917)
Cash flows from investing activities:    
Purchase of property and equipment (146) (48)
Purchase and development of software (142) (948)
Net cash used in investing activities (288) (996)
Cash flows from financing activities:    
Proceeds from exercise of stock options 227 527
Principal payments of 2022 Term Loan Facility 0 (1,688)
Net cash provided by (used in) financing activities 227 (1,161)
Net increase (decrease) in cash and cash equivalents 7,438 (5,074)
Cash and cash equivalents - beginning of period 318,731 585,967
Cash and cash equivalents - end of period 326,169 580,893
Supplemental disclosure of cash flow information:    
Cash (refunded) paid for income taxes (2,906) 615
Cash paid for interest 6,775 13,135
Supplemental disclosure of noncash activities:    
Purchases of software not yet paid 15 22
Purchases of property and equipment not yet paid $ 30 $ 74